Litcius/Paper detail

ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

Gaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, Thomas Gevaert, Karolien Goffin, Valentin Petit, Cindy Mai, Annouschka Laenen, Yannic Raskin, Carl Van Haute, Lieven Goeman, Gert De Meerleer, Charlien Berghen, Wout Devlies, Frank Claessens, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau

2022European Urology72 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstatectomyProstate cancerUrologyClinical endpointPlaceboProstate-specific antigenNeoadjuvant therapyProstateBiopsyRandomized controlled trialInternal medicineOncologyCancerPathologyBreast cancerAlternative medicineProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and Applications
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer | Litcius